Gastro-esophageal Reflux Disease (GERD) Completed Phase 4 Trials for Esomeprazole (DB00736)

Also known as: Gastroesophageal Reflux Disease / Gastro-esophageal Reflux Disease / GERD / GERD Gastroesophageal Reflux Disease / Gastro-Oesophageal Reflux Disease / Gastrooesophageal reflux disease / GERD (Gastroesophageal Reflux Disease) / Esophageal Reflux / GERD - Gastro-Esophageal Reflux Disease / Gastroesophageal Reflux Disease (GERD) / Gastro-esophageal Reflux Diseases / Oesophageal reflux / Esophagitis / Gastrooesophageal reflux / Gastroesophageal reflux / Esophageal reflux NOS

IndicationStatusPhase
DBCOND0077290 (Gastro-esophageal Reflux Disease (GERD))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00206180NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis
NCT00272701Esomeprazole in PPI Failures - IMPROVETreatment
NCT00343161Symptom Adapted Therapy in GERD PatientsTreatment
NCT00410592Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERDTreatment
NCT00626262Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and ivTreatment
NCT00625495Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)Treatment
NCT00637845Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)Treatment
NCT00660660Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study USTreatment
NCT00734097A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)Treatment
NCT01397084To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving RabeprazoleTreatment
NCT00384592PPI Sequencing StudyTreatment
NCT00242736An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)Treatment
NCT00287339The Utility of Nexium in Chronic Cough and Reflux DiseaseTreatment
NCT00318084PPI Test in GP PatientsTreatment
NCT00318968Nexium RESPONSE TrialDiagnostic
NCT00444275Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD PatientsTreatment
NCT00635414Open, Randomized, Two Way Crossover 40mg, Orally and IntravenouslyTreatment
NCT00629564An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)Treatment
NCT00228527Esomeprazole for Treatment of GERD in Pediatric PatientsTreatment
NCT00574925Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected PatientsTreatment
NCT00628342A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)Treatment